Our further analysis of the large TCGA breast cancer subtype cohort showed that these genes are expressed at significantly higher levels in TNBC tumors compared to luminal (ER-positive) and HER2-enriched breast cancers and hence suggests a key role in disease pathogenesis in TNBC subtype (Fig. 3C). The gene discussed is ERBB2; the disease is breast carcinoma.